Global Urology and Pelvic Health Market is forecasted to witness a CAGR of 8% by 2027

Urology and pelvic health is a medical and surgical specialty involving disorders of the genitourinary tract and the adrenal glands. Urologists addresses the conditions affecting kidneys, ureters, bladder, and urethra in both men and women. The global urology and pelvic health market is segmented on the basis of product, application, and end-user.

Technological Innovations and Developments in the Urology and Pelvic Health Market

Recent advancements, innovations and developments in the urology and pelvic health market have enabled manufacturers to develop efficient medical products with excellent capabilities such as minimally invasive approach, fast recovery and reduced healthcare infections. All top companies axcross the world have recently launched their advanced medical products to expand their geographic reach and dominate their position in the urology and pelvic health market. 

Some of the technological advancements are listed below:

  • In November 2022, Teleflex launched its UroLift System in India, a minimally invasive approach for the treatment of benign prostatic hyperplasia (BPH) or prostate enlargement providing a rapid symptomatic relief for men allowing quick recovery.
  • In November 2022, Coloplast launched SpeediCath Flex Set, a new catheter in the US market, featuring a triple action coating technology specifically designed to reduce the risk of Urinary Tract Infections (UTIs) and urethral damage.
  • In September 2022, Olympus Corporation launched its VISERA ELITE III Surgical Visualization Platform that support imaging functions and minimally invasive therapies, to address the needs of healthcare professionals for endoscopic procedures including urology.

Heavy Investments by Market Companies in the Urology and Pelvic Health Market to Trigger the Product Development

All leading and well-established companies operating in the urology and pelvic health market are focusing on investments, developments and collaborations for advancing new product development. These investments are targeted at boosting the technological capabilities of companies aiming at new product development which offers a competitive advantage to the company and its users. Such advancements and partnerships tend to provide a severe advantage to all manufacturers. 

North America is anticipated to hold a Larger Share in the Urology and Pelvic Health Market

From a geographical outlook, North America is poised to hold a larger market share in the urology and pelvic health market. This can be mainly attributed to the investments made by hospitals to procure the advanced medical devices for urology and pelvic health, favorable reimbursement policies and fully developed healthcare infrastructures.

Competitive Landscape Analysis: Urology and Pelvic Health Market

The global urology and pelvic health market is marked by the presence of well-established market companies such as listed below: -

  • Boston Scientific Corporation (US)
  • Medtronic plc (Ireland)
  • Coloplast (Denmark)
  • B. Braun Melsungen AG (Germany)
  • ConvaTec Group (UK)
  • Hollister Incorporated (US)
  • Teleflex Inc. (US)
  • Stryker Corporation (US)
  • Ethicon (US)
Some of the major hurdles to the growth of the urology and pelvic health market are increased costs of advanced medical devices, unfavorable reimbursement situations, and shortage of experienced professionals. Irrespective of these hurdles, the global urology and pelvic health market is set to grow at a decent due to a growing focus of market companies on new product development. Consistent advancements in terms of minimally-invasive approach, decline in subsequent infections, and high cases of kidney diseases, among others, are projected to further drive the growth of the worldwide market.

GET Detailed Insights on Urology and Pelvic Health Market Report @ https://meditechinsights.com/urology-and-pelvic-health-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Medical Display Market is projected to witness a CAGR of 5% by 2027 - Transforming Medical Imaging

Medical displays are purpose-built solutions which offer quick improvements in viewing angle, longevity, luminance, and noise reduction to assure substantially superior accuracy and effectiveness of medical images. Technological Developments and Innovations in Medical Display Drives the Growth of the Global Medical Display Market With the rapid innovations and developments in medical technology, many high-end medical equipment's are being introduced in the global market. Flat-panel displays, holograms, and head-mounted displays are quickly changing the manner in which medical messages are being communicated. The majority of displays used for medical imaging are liquid crystal displays (LCDs) backlit with either CCFLs or LEDs.  For instance,  In January 2023, Barco announced the release of a new LED solution which completes its next-generation LED portfolio. Adoption of Multimodality Display Fuels the Global Growth of the Medical Display Market  With the fast evolution of the medi
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more